recent met ceo rich tobin cfo brad cerepak vice-president corpor
develop ir andrey galiuk come away increment posit
near/intermediate-term outlook topic includ surpris sinc mr tobin assum
post may effici cost takeout distinct posit refriger weak
unsurpris neg busi trend approach gener favor
capit deploy strategi consist messag overal believ solidli
posit low-single-digit core sale growth follow low/mid-single-digit
high-single-digit ep growth increment capit deploy
afford upsid encourag oper momentum
remain patient bar valuat pullback and/or confid sustain rfe
growth materi margin/return expans
de soon report revenu ebit split engin product imag
 identif like sustain core growth strength esg ddp
key driver organ segment book outlook variabl
vsg mi although manag sound confid opportun across
busi regard profit ddp momentum vsg cost action support
fluid fuel solut pump process separ report also
appear well posit solid growth margin expans go forward
quarterli lumpi continu includ difficult comp
gener industri demand moder off-set strong medical/biopharma
trend overal top- bottom-lin momentum continu next year
emv air pocket consider
rfe remain overhang oper perform stori although
improv door case order/backlog trend expect shift aluminum
packag footprint consolidation/autom invest suggest stronger
margin pressur duplic cost unknown regard project execut
competit risk
estim maintain ep lift ep
credit higher net cost save particularli
rfe stronger anticip margin progress across platform
improv visibl pend five-seg structur accret
capit deploy still-robust pipelin dri powder
repres upsid lever vs model
year price histori
dover corp diversifi global
manufactur annual revenu
three oper segment
engin system fluid
analyst certif import disclosur see disclosur
appreci dover signific transform
year shed non-industri asset establish
streamlin multi-industri portfolio believ well
posit long-term growth across es fluid platform
ep upsid driven volum leverag continu
oper improv remain catalyst
suspect medium-term focu organ opportun within core
busi post-api spin although strong gener
like support share look either organ growth
margin upsid vs our/consensu model get construct
rfe segment largest variabl view
lsd organ growth es fluids-weight near
solid near-term oper margin expans driven strong
convers es fluid increment restructur action
stronger expect outdoor emv cycl adopt like extend
increas revenu profit contribut wayn acquisit
accret large-scal share repurchas
sustain strength gener industri spend equat higher
anticip organ growth across segment relat im
better anticip execut rfe reinvigor top
line stabilizing/improv margin
reacceler share buyback plan complet
meaning declin gener industri spend
delay beyond effici gain refriger
misstep integr and/or overpay futur deal
quarterli sale profit segment
note tulsa winch report es bear compress report fluid segment contribut estim
compani report oppenheim co inc
sale
sell administr expens
analysi oper
total revenu
segment profit
note tulsa winch report es bear compress report fluid segment contribut estim
